F2RL1 and atopic eczema: Taking into consideration the chronic inflammation of skin barriers, NDGA decreased protease activated receptor 2 (PAR2)-induced inflammatory responses, including IL-8 and ICAM-1 expression in keratinocytes, and recovered skin barrier and atopic dermatitis in hairless mice [171].